Summary
The etiology of disseminated intravascular coagulation (DIC) in preeclampsia is not well understood. We measured plasma levels of fibronectin (FN), which may reflect endothelial cell injury, fibrinopeptide A (FPA), a specific marker of clotting, platelet counts (PLC) and mean platelet volumes (MPV), as well as β-thromboglobulin (βTG) and platelet factor 4 (Pf4), products of irreversible platelet activation in 24 preeclamptic patients and 24 controls matched for age, gestational age, labor status, and parity. In preeclampsia, FN and FPA were significantly elevated while PLC were significantly decreased (P<0.0001, <0.05 and <0.01, respectively). βTG, Pf4, and MPV values did not show significant differences. These findings support the hypothesis that endothelial injury, clotting activation and platelet consumption are increased in preeclampsia. However, the much closer association of preeclampsia with FN levels as compared to FPA, βTG, Pf4, suggests that endothelial injury is a more basic mechanism of preeclampsia than clotting or platelet activation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bick RL (1985) Pathophysiology of hemostasis and thrombosis. In: Sodeman WA Jr, Sodeman TM (eds) Sodeman’s pathologic physiology: mechanisms of diseases, 7th edn. W. B. Saunders, Philadelphia London Toronto, p 705
Csaicsich P, Deutinger J, Tatra G (1989) Platelet specific proteins (β-thromboglobulin and platelet factor 4) in normal pregnancy and pregnancy complicated by preeclampsia. Arch Gynecol Obstet 244:91–95
Graninger W, Tara G, Pirich K, Nasr F (1985) Low antithrombin III and high fibronectin in preeclampsia. Eur J Obstet Gynecol Reprod Biol 19:223–229
Kobayashi T, Terao T (1987) Preeclampsia as chronic disseminated intravascular coagulation. Gynecol Obstet Invest 24:170–178
Lazarchick J, Stubbs TM, Ramein L, Van Dorsten JP, Loadholt CB (1986) Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol 154:1050–1052
Leiberman JR, Hagay ZJ, Mazor M, Aharon M, Nathan I, Dvilanski A (1988) Plasma and urine β-thromboglobulin in severe preeclampsia. Arch Gynecol Obstet 243:165–168
Lockwood CJ, Peters JH (1990) Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 162:358–362
Pekonen E, Rasi V, Ammala M, Vrinikka L, Ylikorkala O (1986) Platelet function and coagulation in normal and preeclamptic pregnancy. Thromb Res 43:553–560
Pritchard JA, Cunningham FG, Mason RA (1976) Coagulation changes in eclampsia: Their frequency and pathogenesis. Am J Obstet Gynecol 124:855–864
Rappaport VJ, Hirata G, Yap HK, Jordan SC (1990) Anti-vascular endothelial cell antibodies in severe preeclampsia. Am J Obstet Gynecol 162:138–146
Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughli MK (1989) Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 161:1200–1204
Saleh AA, Bottoms SF, Welch RA, Ali AM, Mariona FG, Mammen EF (1987) Preecplampsia, delivery, and the hemostatis system. Am J Obstet Gynecol 157:331–336
Saleh AA, Bottoms SF, Norman G, Farag A, Mammen EF (1988) Hemostasis in hypertensive disorders of pregnancy. Obstet Gynecol 71:719–722
Socol ML, Weiner CP, Louis G, Rehnberg K, Rossi EC (1985) Platelet activation in preeclampsia. Am J Obstet Gynecol 151:494–497
Steele BW, Hills JP, Hellman RL, Civantos F, Kent J (1984) Automated fibronectin assay using light scattering optics on a centrifugal analyzer. Clin Biochem 17:157–161
Stubbs TM, Lazarchick J, Horger EO (1984) Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol 150:885–887
Stubbs TM, Lazarchick J, Dorsten PV, Cox J, Loadholt CB (1986) Evidence of accelerated platelet production and consumption in nonthrombocytopenic preeclampsia. Am J Obstet Gynecol 155:263–265
Walenga JM, Hoppensteadt D, Martin ER, Fareed J (1984) Performance characteristics of a single radioimmune assay for fibrinopeptide A. Semin Thromb Hemost 10:219–227
Walker JJ, Cameron AD, Bjornsson S, Singer CR, Fraser C (1989) Can platelet volume predict progressive hypertensive disease in pregnancy? Am J Obstet Gynecol 161:676–679
Walsh SW (1985) Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 152:335–340
Walz DA (1984) Platelet released proteins as molecular markers for the activation process. Semin Thromb Hemost 10:270–279
Weiner CP (1987) The role of serotonin in the genesis of hypertension in preeclampsia. Am J Obstet Gynecol 156:885–888
Weiner CP (1988) The mechanism of reduced antithrombin III activity in women with preeclampsia. Obstet Gynecol 72:847–849
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saleh, A.A., Bottoms, S.F., Farag, A.M. et al. Markers for endothelial injury, clotting and platelet activation in preeclampsia. Arch Gynecol Obstet 251, 105–110 (1992). https://doi.org/10.1007/BF02718370
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02718370